嘉实标普生物科技精选行业ETF(QDII)(159502)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
- |
- |
6,026.04 |
| 存出保证金 |
- |
- |
- |
| 交易性金融资产 |
1,221,870,554.92 |
1,057,142,309.75 |
844,268,519.18 |
| 其中：股票投资 |
1,221,870,554.92 |
1,057,142,309.75 |
844,268,519.18 |
| 债券投资 |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
- |
| 应收申购款 |
- |
- |
- |
| 其他资产 |
- |
- |
- |
| 资产总计 |
1,231,896,898.21 |
1,063,452,814.64 |
870,633,594.01 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
- |
381,361.30 |
19,318,710.87 |
| 应付赎回款 |
- |
- |
- |
| 应付管理人报酬 |
521,708.39 |
390,410.71 |
339,079.04 |
| 应付托管费 |
104,341.68 |
78,082.16 |
67,815.83 |
| 应付销售服务费 |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
78,351.28 |
38,000.00 |
91,995.54 |
| 负债合计 |
704,401.35 |
887,854.17 |
19,817,601.28 |
| 所有者权益 |
| 实收基金 |
1,395,323,019.00 |
1,098,323,019.00 |
859,323,019.00 |
| 未分配利润 |
-164,130,522.14 |
-35,758,058.53 |
-8,507,026.27 |
| 所有者权益合计 |
1,231,192,496.86 |
1,062,564,960.47 |
850,815,992.73 |
| 负债及所有者权益总计 |
1,231,896,898.21 |
1,063,452,814.64 |
870,633,594.01 |
微信公众号
证券之星APP
基本资料
